Combined e-Voting Results alongwith Scrutinizer''s Report.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Eiko Lifesciences held its 48th AGM on September 5, 2025 via video conferencing, where all 8 resolutions were passed. Key items included adoption of audited financial statements for FY ending March 31, 2025, appointment of Secretarial Auditors, approval of material related party transactions, and an increase in authorized share capital. Shareholders also approved the appointment of Mr. Sumukh Prabhakar Vartak as Whole Time Director and re-appointed Mr. Laxmikant Kabra, Ms. Kajal Kothari, and Mr. Rajkumar Baheti to the Board. About 60.31% of outstanding shares (82.74 lakh shares) were voted, with every resolution receiving 99.99% support in favour.
All resolutions passed with near-unanimous shareholder approval, reflecting strong backing for management's proposals including leadership changes and capital structure flexibility. The authorized share capital increase may enable future fundraising, dilution, or stock splits, while low voting turnout by promoter group on related-party and director items signals independent shareholder engagement.